Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 50090-5619

6 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 50090-5619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905619)

Label Image (Lbl500905619)
Label for medroxyprogesterone acetate 150 mg/mL injection suspension by A-S Medication Solutions. The label includes dosage form, concentration, and storage instructions to keep the vial upright at 68 to 77 degrees Fahrenheit. It indicates a 1 mL single-dose vial with product and lot numbers.*
FDA Label Image

Figure 1 (Medroxyprogesterone 01)

Figure 1 (Medroxyprogesterone 01)
A forest plot displaying odds ratios with 95% confidence intervals on a logarithmic scale for seven studies assessing risk associated with medroxyprogesterone acetate (DMPA). The x-axis shows odds ratios from 0.6 to 7.4, and the y-axis lists study names and years. Each study's odds ratio point estimate and confidence interval are plotted horizontally, with a vertical reference line at 1.0 indicating no increased risk.*
FDA Label Image

Chemical Structure (Medroxyprogesterone 02)

Chemical Structure (Medroxyprogesterone 02)
Chemical structure of medroxyprogesterone acetate, depicting its steroid framework with characteristic ketone and acetate functional groups.*
FDA Label Image

Logo (Medroxyprogesterone 03)

FDA Label Image

Image (Medroxyprogesterone 04)

Image (Medroxyprogesterone 04)
A diagram illustrating the relative effectiveness of various birth control methods in reducing pregnancies per 100 women per year. Methods are grouped by decreasing pregnancies from fewer than 1 to 85 or more per 100 women annually, including implants, injections, intrauterine devices, sterilization, birth control pills, patches, vaginal rings with hormones, condoms, diaphragms, abstinence during fertile days, spermicides, withdrawal, and no birth control at all.*
FDA Label Image

Logo (Medroxyprogesterone 05)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.